/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

Allurion Technologies Inc Share Price Today: Live Updates & Key Insights

Allurion Technologies Inc share price today is $0.6806, up -4.29%. The stock opened at $0.72 against the previous close of $0.7111, with an intraday high of $0.729 and low of $0.6806.

Allurion Technologies Inc Share Price Chart

style
pb-0

Allurion Technologies Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

Allurion Technologies Inc Share Price Performance

$0.6806 -0.0429(-4.29%) ALUR at 13 Mar 2026 11:57 AM Medical Devices
Lowest Today 0.6806
Highest Today 0.729
Today’s Open 0.72
Prev. Close 0.7111
52 Week High 4.18
52 Week Low 0.65
Day’s Range: Low 0.6806 High 0.729
52-Week Range: Low 0.65 High 4.18
1 day return -
1 Week return -
1 month return -35.37
3 month return -53.92
6 month return -67.53
1 year return -71.96
3 year return -93.17
5 year return -92.83
10 year return -

Allurion Technologies Inc Institutional Holdings

Allurion Technologies Inc Market Status

Strong Buy: 2

Buy: 1

Hold: 1

Sell: 0

Strong Sell: 0

Allurion Technologies Inc Fundamentals

Market Cap 8.74 M

PB Ratio 0.0

PE Ratio 0.0

Enterprise Value 36.57 M

Total Assets 32.81 M

Volume 219285

Allurion Technologies Inc Company Financials

Annual Revenue FY23:64416000 64.4M, FY22:64211000 64.2M, FY21:38242000 38.2M

Annual Profit FY23:50311000 50.3M, FY22:50726000 50.7M, FY21:29190000 29.2M

Annual Net worth FY23:-73775000 -73.8M, FY22:-37744000 -37.7M, FY21:-12386000 -12.4M

Quarterly Revenue Q3/2025:2658000 2.7M, Q2/2025:3379000 3.4M, Q1/2025:5580000 5.6M, Q3/2024:5367000 5.4M, Q2/2024:11766000 11.8M

Quarterly Profit Q3/2025:1304000 1.3M, Q2/2025:2497000 2.5M, Q1/2025:4161000 4.2M, Q3/2024:3111000 3.1M, Q2/2024:8993000 9.0M

Quarterly Net worth Q3/2025:-11884000 -11.9M, Q2/2025:-9335000 -9.3M, Q1/2025:-1501000 -1.5M, Q3/2024:-9004000 -9.0M, Q2/2024:-2162000 -2.2M

About Allurion Technologies Inc & investment objective

Company Information Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform offers the Allurion Program, a swallowable and procedure-less intragastric balloon for weight loss, as well as provides access to artificial intelligence-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company operates in Spain, France, Turkey, and internationally. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.

Organisation Medical Devices

Employees 134

Industry Medical Devices

CEO Dr. Shantanu K. Gaur M.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow